CRYOPORT, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 261.36K shares, a 6172.04% increase year-over-year.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 626.06K shares, a 96217.54% increase year-over-year.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 887.00 shares, a 99.23% decline year-over-year.
- CRYOPORT, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 4.17K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-09-30 | 261.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2025-06-30 | 626.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | |
| 2025-03-31 | 887.00 shares 10-Q · filed 2025-05-08 | |
| 2024-09-30 | 4.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | |
| 2024-06-30 | 650.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | |
| 2024-03-31 | 115.86K shares 10-Q · filed 2024-05-08 | |
| 2013-12-31 | 150.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13 | |
| 2013-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-18 | |
| 2013-06-30 | 500.00K shares 10-Q · filed 2013-08-14 | |
| 2012-06-30 | 0.00 shares 10-Q · filed 2013-08-14 | |
| 2011-12-31 | 0.00 shares 10-Q · filed 2013-02-14 | |
| 2011-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-09 | |
| 2011-06-30 | 0.00 shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |